We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

147 hedge funds and large institutions have $1.29B invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 40 increasing their positions, 45 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 12

38% more capital invested

Capital invested by funds: $940M → $1.29B (+$354M)

27% more funds holding

Funds holding: 116 → 147 (+31)

0% more funds holding in top 10

Funds holding in top 10: 5 → 5 (0)

11% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 45

33% less call options, than puts

Call options by funds: $3.59M | Put options by funds: $5.32M

Holders
147
Holders Change
+31
Holders Change %
+26.72%
% of All Funds
3.92%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
44
Increased
40
Reduced
45
Closed
12
Calls
$3.59M
Puts
$5.32M
Net Calls
-$1.73M
Net Calls Change
-$5.87M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$18.2M
2
FCM
Farallon Capital Management
California
+$13.5M
3
CCM
Consonance Capital Management
New York
+$12.9M
4
Millennium Management
Millennium Management
New York
+$12.9M
5
PAI
Palo Alto Investors
California
+$12.2M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$39.7M
2
PHS
PFM Health Sciences
California
-$17.1M
3
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$9.9M
4
Citadel Advisors
Citadel Advisors
Florida
-$9.65M
5
BC
Broadfin Capital
New York
-$8.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
BACM
101
Blue Arrow Capital Management
New York
$484K +$450K +15,000 New
Citigroup
102
Citigroup
New York
$473K +$404K +13,447 +1,119%
DS
103
DRW Securities
Illinois
$464K +$432K +14,400 New
MNBTD
104
Moody National Bank Trust Division
Texas
$441K -$321K -10,689 -44%
PPA
105
Parametric Portfolio Associates
Washington
$396K +$369K +12,279 New
Tudor Investment Corp
106
Tudor Investment Corp
Connecticut
$396K +$369K +12,285 New
BNP Paribas Financial Markets
107
BNP Paribas Financial Markets
France
$387K -$160K -5,333 -31%
NI
108
Numeric Investors
Massachusetts
$381K +$354K +11,800 New
UBS AM
109
UBS AM
Illinois
$371K +$39K +1,300 +13%
OTPPB
110
Ontario Teachers' Pension Plan Board
Ontario, Canada
$356K +$78K +2,599 +31%
RJA
111
Raymond James & Associates
Florida
$332K +$309K +10,303 New
Group One Trading
112
Group One Trading
Illinois
$331K +$308K +10,251 New
PIM
113
Partner Investment Management
California
$324K -$396K -13,206 -57%
BAAM
114
Baker Avenue Asset Management
California
$323K – – –
BJL
115
Brighton Jones LLC
Washington
$300K -$127K -4,226 -31%
Simplex Trading
116
Simplex Trading
Illinois
$280K +$261K +8,689 New
JP Morgan Chase
117
JP Morgan Chase
New York
$272K +$253K +8,430 New
DIA
118
Denver Investment Advisors
Colorado
$263K -$90.5K -3,016 -27%
MCM
119
Manchester Capital Management
Vermont
$244K – – –
Citadel Advisors
120
Citadel Advisors
Florida
$242K -$9.65M -321,474 -98%
PIM
121
Provident Investment Management
Michigan
$242K +$225K +7,500 New
QIM
122
Quantitative Investment Management
Virginia
$228K +$213K +7,100 New
GCP
123
GSA Capital Partners
United Kingdom
$223K -$344K -11,471 -62%
Principal Financial Group
124
Principal Financial Group
Iowa
$217K -$123K -4,086 -38%
PCM
125
Prelude Capital Management
New York
$215K +$168K +5,605 +529%
3 4
5
6 7

ANAC Hedge Fund Activity: Q4 2014 in Review

147 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q4 2014, worth a combined $1.29B — up 38% from $940M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new ANAC positions and 12 closed out — a net gain of 32 holders — while 40 added to existing stakes and 45 trimmed.

The largest buyer was Vanguard Group, adding an estimated $18.2M. The largest seller was Wellington Management Group, cutting an estimated $39.7M.

  • 147 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q4 2014, up from 116 in Q3 2014.
  • Funds reported $1.29B of ANACOR PHARMACEUTICALS INC COM stock for Q4 2014, up 38% quarter-over-quarter.
  • 44 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q4 2014 and 12 closed out, a net change of +32 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q4 2014 was Vanguard Group, an estimated $18.2M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q4 2014 was Wellington Management Group, an estimated $39.7M sold.

Based on aggregated 13F filings for Q4 2014.